14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 MGNX stock ended at $14.66. This is 8.66% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 14.66% from a day low at $13.71 to a day high of $15.72.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical MacroGenics prices

Date Open High Low Close Volume
Aug 09, 2016 $30.78 $31.37 $29.98 $31.33 165 700
Aug 08, 2016 $31.68 $32.24 $30.41 $30.62 201 700
Aug 05, 2016 $32.33 $32.33 $31.11 $31.51 227 300
Aug 04, 2016 $31.40 $33.00 $28.35 $32.35 516 700
Aug 03, 2016 $30.06 $31.74 $29.96 $31.63 228 100
Aug 02, 2016 $30.83 $31.06 $29.86 $30.30 241 000
Aug 01, 2016 $30.83 $31.22 $30.46 $30.90 280 000
Jul 29, 2016 $29.83 $31.00 $29.29 $30.59 142 800
Jul 28, 2016 $29.87 $30.37 $29.70 $30.02 247 800
Jul 27, 2016 $29.16 $29.99 $29.07 $29.96 143 100
Jul 26, 2016 $28.57 $29.10 $28.30 $28.97 145 900
Jul 25, 2016 $29.11 $29.11 $28.19 $28.82 104 000
Jul 22, 2016 $28.77 $29.06 $28.14 $28.99 107 600
Jul 21, 2016 $29.18 $29.91 $28.49 $28.76 200 000
Jul 20, 2016 $27.24 $29.06 $27.02 $28.82 205 600
Jul 19, 2016 $28.28 $28.80 $26.97 $27.08 243 400
Jul 18, 2016 $27.35 $28.50 $26.89 $28.43 299 500
Jul 15, 2016 $26.59 $27.33 $25.73 $27.24 226 000
Jul 14, 2016 $26.72 $27.20 $25.95 $26.46 160 700
Jul 13, 2016 $27.71 $27.84 $26.11 $26.21 175 200
Jul 12, 2016 $27.52 $28.00 $26.85 $27.50 208 800
Jul 11, 2016 $27.48 $27.85 $26.98 $27.08 187 300
Jul 08, 2016 $25.90 $27.17 $25.70 $27.11 261 500
Jul 07, 2016 $26.41 $26.41 $25.25 $25.87 264 900
Jul 06, 2016 $25.94 $26.55 $25.48 $26.23 347 600
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT